Insulet (PODD)
(Delayed Data from NSDQ)
$266.57 USD
+10.01 (3.90%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $269.47 +2.90 (1.09%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Insulet (PODD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$288.30 | $340.00 | $234.00 | 12.37% |
Price Target
Based on short-term price targets offered by 20 analysts, the average price target for Insulet comes to $288.30. The forecasts range from a low of $234.00 to a high of $340.00. The average price target represents an increase of 12.37% from the last closing price of $256.56.
Analyst Price Targets (20)
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
Insulet currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on 21 recommendations.
Of the 21 recommendations deriving the current ABR, 17 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80.95% and 4.76% of all recommendations. A month ago, Strong Buy made up 80.95%, while Buy represented 4.76%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 17 | 17 | 17 | 16 | 16 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.33 | 1.35 | 1.35 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
12/18/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
11/11/2024 | Not Identified | Not Identified | Hold | Hold |
11/11/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
11/8/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
11/8/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
11/8/2024 | William Blair | Margaret K Andrew | Strong Buy | Strong Buy |
11/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
11/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
11/8/2024 | UBS | Danielle Antalffy | Hold | Hold |
11/8/2024 | Atlantic Equities | Issie Kirby | Strong Buy | Strong Buy |
11/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
11/6/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
10/15/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
10/14/2024 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
10/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/25/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 21 |
Average Target Price | $290.55 |
LT Growth Rate | 20.30% |
Industry | Medical - Products |
Industry Rank by ABR | 124 of 251 |
Current Quarter EPS Est: | 1.05 |
PODD FAQs
Insulet Corporation (PODD) currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms.
The average price target for Insulet Corporation (PODD) is $290.55. The current on short-term price targets is based on 5 reports.
The forecasts for Insulet Corporation (PODD) range from a low of $234 to a high of $340. The average price target represents a increase of $9.00 from the last closing price of $266.57.
The current UPSIDE for Insulet Corporation (PODD) is 9.00%
Based on short-term price targets offered by 20 analysts, the average price target for Insulet comes to $288.30. The forecasts range from a low of $234.00 to a high of $340.00. The average price target represents an increase of 12.37% from the last closing price of $256.56.